The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 344:1019-1022 March 29, 2001 Number 13
NextNext

Intrathecal Methylprednisolone for Postherpetic Neuralgia

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
To the Editor: Kotani and colleagues (Nov. 23 issue)1 recommend intrathecal methylprednisolone acetate for treatment of intractable postherpetic neuralgia due to persistent inflammation. But the abnormalities in the cerebrospinal fluid and on magnetic resonance imaging in patients with acute herpes zoster are not persistent. The neuropathological reference that Kotani et al. cite2 does not demonstrate polymorphonuclear leukocytes or "marked inflammation around the spinal cord, with massive infiltration and accumulation of lymphocytes." The usual association between neutrophil inflammation and interleukin-8 calls into question reliance on the level of interleukin-8 in acellular cerebrospinal fluid.3 The authors' hypothesis that "postherpetic neuralgia provokes an . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.